We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
3576
DELISTED
Applied Genetic Technologies Corporation
AGTC
$235K ﹤0.01%
305,740
+186,900
+157% +$167K
APRE icon
3577
Aprea Therapeutics
APRE
$7.68M
$234K ﹤0.01%
15,588
+693
+5% +$16K
ENVB icon
3578
Enveric Biosciences
ENVB
$6.32M
$234K ﹤0.01%
121
-100
-45% -$213K
DJCO icon
3579
Daily Journal
DJCO
$809M
$233K ﹤0.01%
+900
New +$242K
VOE icon
3580
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$233K ﹤0.01%
1,800
-7,800
-81% -$1.1M
LYRA
3581
DELISTED
LYRA THERAPEUTICS INC
LYRA
$232K ﹤0.01%
820
+470
+134% +$128K
BRLT icon
3582
Brilliant Earth
BRLT
$17.1M
$231K ﹤0.01%
+48,700
New +$306K
FRLN
3583
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$231K ﹤0.01%
17,682
-12,079
-41% -$155K
ARQT icon
3584
Arcutis Biotherapeutics
ARQT
$3.36B
$230K ﹤0.01%
+10,800
New +$222K
JHMM icon
3585
John Hancock Multifactor Mid Cap ETF
JHMM
$5.92B
$230K ﹤0.01%
+5,200
New +$251K
NNI icon
3586
Nelnet
NNI
$4.88B
$230K ﹤0.01%
2,700
-87,700
-97% -$7.28M
GGRP
3587
Glimpse Group
GGRP
$18.8M
$230K ﹤0.01%
+57,800
New +$254K
ANY icon
3588
Sphere 3D
ANY
$18.5M
$229K ﹤0.01%
6,103
-6,058
-50% -$524K
CLRO icon
3589
ClearOne Inc
CLRO
$10.9M
$229K ﹤0.01%
28,296
-3,206
-10% -$32K
PBW icon
3590
Invesco WilderHill Clean Energy ETF
PBW
$407M
$229K ﹤0.01%
5,000
-38,100
-88% -$2M
SALM
3591
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$229K ﹤0.01%
108,100
-9,600
-8% -$27.1K
GHSI
3592
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$228K ﹤0.01%
31,495
-13,030
-29% -$114K
ADIL
3593
Adial Pharmaceuticals
ADIL
$7.31M
$227K ﹤0.01%
271
+239
+747% +$216K
SWKH
3594
DELISTED
SWK Holdings
SWKH
$227K ﹤0.01%
16,406
-18,299
-53% -$272K
VCLT icon
3595
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$227K ﹤0.01%
+2,800
New +$236K
THRN
3596
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$227K ﹤0.01%
46,800
-84,300
-64% -$513K
BLZE icon
3597
Backblaze
BLZE
$823M
$226K ﹤0.01%
43,300
-14,819
-25% -$111K
SVIX icon
3598
-1x Short VIX Futures ETF
SVIX
$174M
$226K ﹤0.01%
+21,700
New +$249K
CWBR
3599
DELISTED
CohBar, Inc. Common Stock
CWBR
$226K ﹤0.01%
39,790
-12,270
-24% -$82.1K
LZB icon
3600
La-Z-Boy
LZB
$1.58B
$225K ﹤0.01%
+9,500
New +$244K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.